Kairos Pharma KAPA
NYSE KAPA
$0.29 -0.01 (-1.73%)
As of: Aug 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Cash & Equivalents Growth (1y) (2024 - 2025)

Kairos Pharma (KAPA) Cash & Equivalents Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 23.56%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 23.05%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 71.81%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 34.71%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 84.98%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 53.39%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -14.35%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -57.58%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 28.50%
10 Kairos Pharma 5.39 Mn 55,970.58 - 253.07%

Historic Data

Download Data
DateValue
Dec 31, 2025 253.07%
Dec 31, 2024 1,267.74%
Sep 30, 2024 3,149.49%